Brought to you by 
Cogent Neuroscience raises $5.4mm in first round
15 May 2000
Executive Summary
Recently founded Cogent Neuroscience, which hopes to develop drugs to treat neurological diseases and stroke, has raised $5.4mm in its first round. Investors were Bioscience Investment Fund, which contributed $500k, Intersouth Partners, Kitty Hawk Capital, Aurora Ventures, and Cordova Technology Partners.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cogent Neuroscience raises $5.4mm in first round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice